Inhibition of the recruitment of inflammatory cells by the tachykinin NK3 receptor antagonist, SR 142801, in a murine model of asthma

被引：0
|
作者：
Nenan, S. [1 ]
Germain, N. [1 ]
Lagente, V. [1 ]
Emonds-Alt, X. [2 ]
Advenier, C. [3 ]
Boichot, E. [1 ]
机构：
[1] Univ Rennes 1, Fac Pharm, INSERM, U456, F-35014 Rennes, France
[2] Sanofi Synthelabo Rech, Montpellier, France
[3] Univ Paris 05, Lab Pharmacol, F-75270 Paris 06, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2001年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：118 / 118
页数：1
相关论文
共 44 条
  • [1] Inhibition of inflammatory cell recruitment by the tachykinin NK3-receptor antagonist, SR 142801, in a murine model of asthma
    Nénan, S
    Germain, N
    Lagente, V
    Emonds-Alt, X
    Advenier, C
    Boichot, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 421 (03) : 201 - 205
  • [2] Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801
    Beaujouan, JC
    Saffroy, M
    Torrens, Y
    Glowinski, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 319 (2-3) : 307 - 316
  • [3] SR-142801, THE FIRST POTENT NONPEPTIDE ANTAGONIST OF THE TACHYKININ NK3 RECEPTOR
    EMONDSALT, X
    BICHON, D
    DUCOUX, JP
    HEAULME, M
    MILOUX, B
    PONCELET, M
    PROIETTO, V
    VANBROECK, D
    VILAIN, P
    NELIAT, G
    SOUBRIE, P
    LEFUR, G
    BRELIERE, JC
    LIFE SCIENCES, 1994, 56 (01) : PL27 - PL32
  • [4] A practical and scalable synthesis of SR 142801, a tachykinin NK3 antagonist
    Chen, HG
    Chung, FZ
    Goel, OP
    Johnson, D
    Kesten, S
    Knobelsdorf, J
    Lee, HT
    Rubin, JR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (05) : 555 - 560
  • [5] The tachykinin NK3 receptor antagonist SR142801 blocks the behavioral effects of cocaine in marmoset monkeys
    Silva, MAD
    Mello, EL
    Müller, CP
    Jocham, G
    Maior, RS
    Huston, JP
    Tomaz, C
    Barros, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 536 (03) : 269 - 278
  • [6] Effects of a tachykinin NK3 receptor antagonist, SR 142801, studied in isolated neonatal rat spinal cord
    Guo, JZ
    Yoshioka, K
    Otsuka, M
    NEUROPEPTIDES, 1998, 32 (06) : 537 - 542
  • [7] Interaction of the tachykinin NK3 receptor antagonist, SR142801, with MMP-2 production from human lung fibroblasts
    Martin-Chouly, C. A. E.
    Depince, A.
    Lagente, V.
    Advenier, X. C.
    Edmonds-Alx
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 83 - 83
  • [8] A tachykinin NK3 receptor antagonist, SR 142801 (Osanetant), prevents substance P-induced bronchial hyperreactivity in guinea-pigs
    Daoui, S
    Cui, YY
    Lagente, V
    Emonds-Alt, X
    Advenier, C
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 1997, 10 (5-6) : 261 - 270
  • [9] FUNCTIONAL-CHARACTERIZATION OF THE NONPEPTIDE NEUROKININ3 (NK3) RECEPTOR ANTAGONIST, SR142801 ON THE HUMAN NK3 RECEPTOR EXPRESSED IN CHINESE-HAMSTER OVARY CELLS
    OURYDONAT, F
    CARAYON, P
    THURNEYSSEN, O
    PAILHON, V
    EMONDSALT, X
    SOUBRIE, P
    LEFUR, G
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 274 (01): : 148 - 154
  • [10] Molecular and pharmacological characterization of the murine tachykinin NK3 receptor
    Sarau, HM
    Feild, JA
    Ames, RS
    Foley, JJ
    Nuthulaganti, P
    Schmidt, DB
    Buckley, PT
    Elshourbagy, NA
    Brawner, ME
    Luttmann, MA
    Giardina, GAM
    Hay, DWP
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 413 (2-3) : 143 - 150
12345